Literature DB >> 1604321

Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells.

K L Philpott1, J L Viney, G Kay, S Rastan, E M Gardiner, S Chae, A C Hayday, M J Owen.   

Abstract

Vertebrate T cells express either an alpha beta or gamma delta T cell receptor (TCR). The developmental relatedness of the two cell types is unresolved. alpha beta + T cells respond to specific pathogens by collaborating with immunoglobulin-producing B cells in distinct lymphoid organs such as the spleen and Peyer's patches. The precise influence of alpha beta + T cells on B cell development is poorly understood. To investigate the developmental effects of alpha beta + T cells on B cells and gamma delta + T cells, mice homozygous for a disrupted TCR alpha gene were generated. The homozygotes showed elimination of alpha beta + T cells and the loss of thymic medullae. Despite this, gamma delta + T cells developed in normal numbers, and there was an increase in splenic B cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1604321     DOI: 10.1126/science.1604321

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  98 in total

1.  The expansion of human gammadelta T cells in response to Daudi cells requires the participation of CD4+ T cells.

Authors:  J D Fayen; M L Tykocinski
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

2.  CD4+ T cells derived from B cell-deficient mice inhibit the establishment of peripheral B cell pools.

Authors:  N Baumgarth; G C Jager; O C Herman; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

3.  Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme.

Authors:  T D Camenisch; A P Spicer; T Brehm-Gibson; J Biesterfeldt; M L Augustine; A Calabro; S Kubalak; S E Klewer; J A McDonald
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 4.  Thymic stromal cell subsets for T cell development.

Authors:  Takeshi Nitta; Harumi Suzuki
Journal:  Cell Mol Life Sci       Date:  2016-01-29       Impact factor: 9.261

5.  Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance.

Authors:  C D Schmid; M Stienekemeier; S Oehen; F Bootz; J Zielasek; R Gold; K V Toyka; M Schachner; R Martini
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

6.  Molecular signature of recent thymic selection events on effector and regulatory CD4+ T lymphocytes.

Authors:  Paola Romagnoli; Denis Hudrisier; Joost P M van Meerwijk
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

7.  Cancer immunotherapy using a bispecific NK receptor fusion protein that engages both T cells and tumor cells.

Authors:  Tong Zhang; Charles L Sentman
Journal:  Cancer Res       Date:  2011-01-31       Impact factor: 12.701

8.  TRAF3 enforces the requirement for T cell cross-talk in thymic medullary epithelial development.

Authors:  S Rhiannon Jenkinson; Joy A Williams; Hyein Jeon; Jingjing Zhang; Takeshi Nitta; Izumi Ohigashi; Michael Kruhlak; Saulius Zuklys; Susan Sharrow; Anthony Adams; Larry Granger; Yongwon Choi; Ulrich Siebenlist; Gail A Bishop; Georg A Hollander; Yousuke Takahama; Richard J Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

9.  Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement.

Authors:  C Tsatsanis; R Fulton; K Nishigaki; H Tsujimoto; L Levy; A Terry; D Spandidos; D Onions; J C Neil
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Differential regulation of IL-4Ralpha expression by antigen versus cytokine stimulation characterizes Th2 progression in vivo.

Authors:  Georgia Perona-Wright; Katja Mohrs; Katrin D Mayer; Markus Mohrs
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.